Real-time enrollment status for this migraine clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT07116499 |
| Recruiting Status | Terminated |
| Condition | Migraine |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Kallyope Inc. |
| Last Updated on CT.gov | November 25, 2025 (Nov 25, 2025) |
As of March 2, 2026: Clinical trial NCT07116499 is currently terminated participants. This clinical trial study for migraine is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Kallyope Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07116499 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07116499 was last updated Nov 25, 2025 (November 25, 2025). HelloStudys verifies this status automatically.